Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionWalleye Capital LLC
Latest Disclosed Ownership30,752 shares
Latest Disclosed Value $ 13,731,998
Walleye Capital LLC ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 30,752 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $13,731,998 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 14,974 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 105.37% during the quarter. The current value of the position is $13,172,312 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 5,500 of underlying shares valued at $2,455,970 USD and put options representing 9,900 of underlying shares valued at $4,420,746 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 30,752 15,778 105.37 13,732 102.28 0.0571
2026-05-08 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 30,752 15,778 13,732 0.0571
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 14,974 12,512 508.20 6,789 604.15 0.0208
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,462 2,130 641.57 964 555.78 0.0036
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 332 -3,071 -90.24 148 -91.09 0.0006
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,403 3,225 1,811.80 1,650 2,222.54 0.0074
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 178 -5,203 -96.69 72 -97.16 0.0002
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,381 2,596 93.21 2,503 91.72 0.0052
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,785 -54 -1.90 1,305 10.03 0.0023
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,839 -9,416 -76.83 1,187 -76.21 0.0021
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 12,255 -14,090 -53.48 4,986 -45.57 0.0106
2023-11-21 2023-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 26,345 26,345 9,161 0.0234
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 26,345 26,345 9,161 0.0236
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -9,328 -100.00 0 -100.00
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 9,328 -46,509 -83.29 2,939 -81.78 0.0440
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 55,837 -11,186 -16.69 16,125 -16.91 0.2940
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 67,023 37,649 128.17 19,406 134.46 0.3703
2022-08-19 2022-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 29,374 16,634 130.57 8,277 148.93 0.2281
2022-08-08 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 29,374 16,634 8,277 0.2281
2022-05-27 2022-03-31 13F/A-01 VERTEX PHARMACEUTICALS COM 92532F100 12,740 -18,463 -59.17 3,325 -51.47 0.0889
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 12,740 -18,463 3,325 0.0677
2022-05-27 2021-12-31 13F/A-01 VERTEX PHARMACEUTICALS COM 92532F100 31,203 2,373 8.23 6,852 31.04 0.2128
2022-03-03 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 31,203 2,373 6,852 0.1713
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 28,830 -2,601 -8.28 5,229 -17.48 0.1482
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 31,431 29,963 2,041.08 6,337 1,911.75 0.2160
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,468 1,468 315 0.0183
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -3,428 -100.00 0 -100.00
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,428 3,428 933 0.1040
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -3,818 -100.00 0 -100.00
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,818 1,598 71.98 908 86.83 0.1999
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,220 1,750 372.34 486 507.50 0.0315
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 470 190 67.86 80 56.86 0.0048
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 280 -110 -28.21 51 -29.17 0.0056
2019-08-14 2019-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 390 390 72 0.0119
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 390 72 0.0119
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 5,500 -30.38 2,456 -31.44 n/a n/a n/a
2026-05-08 2026-03-31 13F VERTEX PHARMACEUTICALS COM Call 5,500 2,456 n/a n/a n/a
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM Call 7,900 16.18 3,582 34.47 n/a n/a n/a
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM Call 6,800 -46.46 2,663 -52.90 n/a n/a n/a
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM Call 12,700 -9.29 5,654 -16.69 n/a n/a n/a
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM Call 14,000 97.18 6,787 137.39 n/a n/a n/a
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS COM Call 7,100 -59.89 2,859 -65.27 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 17,700 12.03 8,232 11.15 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 15,800 -49.03 7,406 -42.85 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Call 31,000 737.84 12,958 761.00 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 3,700 -50.67 1,505 -42.29 n/a n/a n/a
2023-11-21 2023-09-30 13F/A VERTEX PHARMACEUTICALS COM Call 7,500 0.00 2,608 -1.17 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 7,500 2,608 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Call 7,500 -10.71 2,639 -0.26 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 8,400 33.33 2,647 45.46 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 6,300 350.00 1,819 349.14 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 1,400 405 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Call 31,100 -64.90 6,809 -54.64 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM Call 88,600 223.36 15,011 198.73 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM Call 27,400 166.02 5,025 165.17 n/a n/a n/a
2019-08-14 2019-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 10,300 1,895 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Call 10,300 1,895 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 9,900 -32.19 4,421 -33.22 n/a n/a n/a
2026-05-08 2026-03-31 13F VERTEX PHARMACEUTICALS COM Put 9,900 4,421 n/a n/a n/a
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM Put 14,600 2,333.33 6,619 2,728.63 n/a n/a n/a
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM Put 600 -93.55 235 -94.35 n/a n/a n/a
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM Put 9,300 -10.58 4,140 -17.89 n/a n/a n/a
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 10,400 73.33 5,042 108.69 n/a n/a n/a
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 6,000 -53.12 2,416 -59.42 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Put 12,800 -31.55 5,953 -32.08 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 18,700 -54.94 8,765 -49.47 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 41,500 332.29 17,347 344.11 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 9,600 -82.35 3,906 -79.35 n/a n/a n/a
2023-11-21 2023-09-30 13F/A VERTEX PHARMACEUTICALS COM Put 54,400 1,260.00 18,917 1,244.49 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 54,400 18,917 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Put 4,000 -37.50 1,408 -30.21 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 6,400 10.34 2,016 20.43 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 5,800 3.57 1,675 3.27 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 5,600 1,621 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Put 1,900 -85.82 452 -84.59 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Put 13,400 38.14 2,934 78.58 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM Put 9,700 38.57 1,643 27.96 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM Put 7,000 775.00 1,284 773.47 n/a n/a n/a
2019-08-14 2019-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 800 147 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Put 800 147 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.